Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Sunday, Nov 12th
    4:00 PM – 5:00 PM PT
    12S158: New Developments in Pediatric Sjögren’s Disease
    Location: Room 8
    Moderator: Scott Lieberman, MD, PhD – University of Iowa
    Moderator: Akaluck Thatayatikom, MD, RhMSUS – AdventHealth for Children
    Sjögren’s syndrome
     CME: 1 hours
  • Sunday, Nov 12th
    4:00 PM – 4:15 PM PT
    Clinical Manifestations and Diagnosis of Sjögren's in Children
    Location: Room 8
    Sjögren’s syndrome
  • Sunday, Nov 12th
    4:15 PM – 4:30 PM PT
    Evaluation and Management of Sialadenitis in Childhood Sjögren's Patients
    Location: Room 8
    Speaker: Sara Stern, MD (she/her/hers) – University of Utah
    Sjögren’s syndrome
  • Sunday, Nov 12th
    4:30 PM – 4:45 PM PT
    Reproductive Health Needs Unique to Adolescent and Young Adult Women with Sjögren's Disease
    Location: Room 8
    Speaker: Cuoghi Edens, MD, FAAP – University of Chicago
    Sjögren’s syndrome
  • Sunday, Nov 12th
    4:45 PM – 5:00 PM PT
    Q&A
    Location: Room 8
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1365–1382) Sjögren’s Syndrome – Basic & Clinical Science Poster I
    Location: Poster Hall
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1365: Extraglandular Involvement and Autoantibody Status as Risk Factors for Cardiovascular Disease in Primary Sjogren’s Syndrome (pSS): A 20 Year-follow up Study
    Location: Poster Hall
    Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Complejo Asistencial Universitario de León
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1366: A Unique Cluster of Inflammatory Monocytes and Functionally Intact Regulatory T Cells in Rare Childhood Sjögren’s Disease
    Location: Poster Hall
    Abstract Poster Presenter: Myeongcheol Kim, PhD, DVM – Jeju National University
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1367: Novel Autoantibodies Might Circumvent the Need for Labial Biopsy in a Subset of Seronegative Sjögren’s Disease Patients
    Location: Poster Hall
    Abstract Poster Presenter: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1368: Development of the Sjögren’s-related Quality of Life (SRQoL) to Assess Health-related Quality of Life (HRQoL) in Sjögren’s
    Location: Poster Hall
    Abstract Poster Presenter: Benjamin A. Fisher, MD, MBBS – University of Birmingham
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1369: Treatment Patterns and Drivers of Biologic Prescriptions in Patients with Primary Sjögren's Disease: Results from a Multinational, Real-World Survey
    Location: Poster Hall
    Abstract Poster Presenter: Ann Xi, PharmD – Horizon Therapeutics
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1370: Synthetic Glabridin Derivatives Improves Sjogren’s Syndrome by Inducing Salivary Secretion and Salivary Gland Regeneration
    Location: Poster Hall
    Abstract Poster Presenter: Eui-Jong Kwon, MD (he/him/his) – The Catholic University of Korea Seoul St. Mary's Hospital
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1371: Are Ultrasound Salivary Parenchymal Abnormalities More Severe in Primary Sjögren Patients with a Higher Disease Duration ? A Cross-sectional International Study
    Location: Poster Hall
    Abstract Poster Presenter: Valerie Devauchelle, MD, PhD – UBO
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1372: Obinutuzumab Efficacy and Tolerance in Patients with Auto-Immune Diseases Immunized Against Rituximab
    Location: Poster Hall
    Abstract Poster Presenter: Samuel Bitoun, MD, PhD – CHU Bicêtre APHP
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1373: Deltex1 May Involve the Function of T Regulatory Cells and Regulate the Disease Activity of Sjögren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Ming-Han Chen, PhD (he/him/his) – Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1374: Interstitial Lung Disease Is Frequent in Primary Sjögren’s Syndrome and Is Associated with Reduced Survival
    Location: Poster Hall
    Abstract Poster Presenter: Marco Sprecher, MD – Universitätsspital Zürich (University Hospital Zurich)
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1375: The Relative Burden of Fatigue Is Associated with High TSH/fT4 Ratio in Korean Patients with Primary Sjogren's Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Jee-in Lee, MD (she/her/hers) – Seoul National University of Bundang hospital
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1376: SJOGRENSER Registry: Prospective Evaluation of a Cohort of Patients with Primary Sjögren's Syndrome After 8 Years of Follow-up
    Location: Poster Hall
    Abstract Poster Presenter: Zulema Plaza, PhD, MSc – Fundacion Española de Reumatología
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1377: Characterization of Pulmonary Manifestations of Sjögren Syndrome: A Multicenter Retrospective Study
    Location: Poster Hall
    Abstract Poster Presenter: Loïc Meudec, MD – Université Paris-Saclay
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1378: The UCSD Shortness of Breath Questionnaire Is a Useful Tool for the Assessment of Dyspnea in Primary Sjögren’s Syndrome Patients with Interstitial Lung Disease: A Monocentric Cross-Sectional Study
    Location: Poster Hall
    Abstract Poster Presenter: Gaetano La Rocca, MD – University of Pisa, Rheumatology Unit
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1379: Population Pharmacokinetic/Pharmacodynamic Modeling of Dazodalibep, a CD40L Antagonist, in Healthy Volunteers and Patients with Rheumatoid Arthritis and Sjogren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Kenneth Der, BS – Horizon Therapeutics
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1380: Synergistic Dose Effects of Extra X Chromosome in Development of Sjogren's Syndrome in Klinefelter and Triple X Syndromes
    Location: Poster Hall
    Abstract Poster Presenter: Anna-Kay Palmer, MD, MBBS – Albert Einstein Medical Center
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1381: Fatigue and Associated Factors in Patients with Primary Sjogren's Syndrome Compared to Secondary Sjogren's Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: HYEJI JEON, MD – Soonchunhyang University Hospital Seoul
    Sjögren’s syndrome
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1382: Efficacy of Tofacitinib Immunotherapy Suppresses Tfh and Tph Cells in Patients with Primary Sjögren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Qinghong Liu, MBBS – Peking University People's Hospital
    Sjögren’s syndrome
  • Monday, Nov 13th
    2:00 PM – 3:30 PM PT
    13M149: Abstracts: Sjögren’s Syndrome – Basic & Clinical Science (1633–1638)
    Location: Room 5A-B
    Abstract Moderator: Dana DiRenzo, MD, RhMSUS, MHS – University of Pennsylvania
    Abstract Moderator: Jennifer King, MD, PhD – UCLA
    Sjögren’s syndrome
  • Monday, Nov 13th
    2:00 PM – 2:10 PM PT
    1633: Dose Dependent Modulation of a B Cell Protein Signature by Ianalumab in Patients with Sjögren’s Disease
    Location: Room 5A-B
    Presenting Author: Stephanie Finzel, MD – University Medical Center Freiburg
    Sjögren’s syndrome
  • Monday, Nov 13th
    2:15 PM – 2:25 PM PT
    1634: Iscalimab (CFZ533) in Patients with Sjögren’s Disease: Week 24 Efficacy and Safety Results of a Randomized, Placebo-controlled, Phase 2b Dose-ranging Study
    Location: Room 5A-B
    Presenting Author: Benjamin A. Fisher, MD, MBBS – University of Birmingham
    Sjögren’s syndrome
  • Monday, Nov 13th
    2:30 PM – 2:40 PM PT
    1635: Deep Learning Accurately Predicts Focus Score and Diagnosis of Primary Sjögren Syndrome Using Labial Salivary Gland Biopsies
    Location: Room 5A-B
    Presenting Author: Vincent Bouget, MSc – Scienta Lab
    Sjögren’s syndrome
  • Monday, Nov 13th
    2:45 PM – 2:55 PM PT
    1636: Dazodalibep, a CD40L Antagonist, in Subjects with Sjögren’s Having Moderate-to-Severe Systemic Disease Activity: Full Crossover Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study
    Location: Room 5A-B
    Presenting Author: Eugene St.Clair, MD – Duke University Medical Center
    Sjögren’s syndrome
  • Monday, Nov 13th
    3:00 PM – 3:10 PM PT
    1637: IgG-Fc-N-Sialylation and -Galactosylation in Primary Sjögren’s Syndrome (Pss) in Its Potential as Marker of Disease State and Disease Activity
    Location: Room 5A-B
    Presenting Author: Helena Achten, MD (she/her/hers) – Ghent University
    Sjögren’s syndrome
  • Monday, Nov 13th
    3:15 PM – 3:25 PM PT
    1638: CD40L Inhibition with Dazodalibep Rapidly Reduces Blood Biomarkers of T and B Cell Costimulation in Subjects with Sjögren’s Having High Disease Activity or High Symptom Burden
    Location: Room 5A-B
    Presenting Author: Tuyet-Hang Pham, MS – Horizon Therapeutics plc
    Sjögren’s syndrome
  • Monday, Nov 13th
    4:00 PM – 5:00 PM PT
    13M156: Challenging Complications of the Nervous System in Sjögren's Syndrome
    Location: Room 1A-B
    Moderator: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
    Moderator: Thomas Grader-Beck, MD – Division of Rheumatology, Johns Hopkins School of Medicine
    Sjögren’s syndrome
     CME: 1 hours
  • Monday, Nov 13th
    4:00 PM – 4:15 PM PT
    The Approach to Evaluating Dysautonomia in Sjögren's Disease
    Location: Room 1A-B
    Speaker: Brent Goodman, MD – Mayo Clinic
    Sjögren’s syndrome
  • Monday, Nov 13th
    4:15 PM – 4:30 PM PT
    Update on the Pathogenesis of Migraines in Sjögren's Disease
    Location: Room 1A-B
    Speaker: Arun Varadhachary, MD, PhD – Washington University in St. Louis
    Sjögren’s syndrome
  • Monday, Nov 13th
    4:30 PM – 4:45 PM PT
    Practical Management Strategies for Neurologic Complications of Sjögren's Disease
    Location: Room 1A-B
    Speaker: Julius Birnbaum, MD – 1 University of Pittsburgh Medical Center
    Sjögren’s syndrome
  • Monday, Nov 13th
    4:45 PM – 5:00 PM PT
    Q&A
    Location: Room 1A-B
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II
    Location: Poster Hall
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L10: Dazodalibep, a CD40L Antagonist, in a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of Subjects with Sjögren’s Disease Having Unacceptable Symptomatic Burden but Limited Extraglandular Organ Involvement
    Location: Poster Hall
    Late-Breaking Poster Presenter: Eugene St.Clair, MD – Duke University Medical Center
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2177: Characterization of Crevicular Fluid Microbiota in Primary Sjögren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Gabriela Hernandez-Molina, MD, MS – Instituto Nacional de Ciencias Medicas y Nutricion
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2178: Increased Risk of Dementia in Patients with Primary Sjogren's Syndrome: A Nationwide Population-based Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: HYEJI JEON, MD – Soonchunhyang University Hospital Seoul
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2179: Disease Burden of Patients with Primary Sjögren’s Disease: Results from a Multinational Real-World Survey
    Location: Poster Hall
    Abstract Poster Presenter: Ann Xi, PharmD – Horizon Therapeutics
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2180: Salivary and Plasma Mitochondrial Double-strand RNAs as a Diagnostic Biomarker for Sjӧgren Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: SE RIM CHOI, MD – Seoul National University
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2181: Secretagogue Effect of PDE4 Inhibitor Apremilast on Human Salivary Gland Organoids Obtained from Primary Sjögren's Syndrome Patients
    Location: Poster Hall
    Abstract Poster Presenter: Valeria Manfrè, MD – Division of Rheumatology, Department of Medicine, University of Udine, Udine, Italy
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2183: Evolution of Lymphoma Predictors in Primary Sjogren’s Syndrome by Data Driven Analysis in Harmonized Patients
    Location: Poster Hall
    Abstract Poster Presenter: Andreas Goules – Dept. of Pathophysiology, School of Medicine, University of Athens
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2184: Development of Salivary Gland Organoids to Study Sjögren Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Loïc Meudec, MD – Université Paris-Saclay
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2185: 35 Years Follow-up of Primary Sjögren’s Disease: A Single Center Study
    Location: Poster Hall
    Abstract Poster Presenter: David Isenberg, MD, FRCP – University College London
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2186: Neurological Complications in Sjögren’s: Occurrence & Impact on Patient Quality of Life
    Location: Poster Hall
    Abstract Poster Presenter: Matt Makara, MPH – Sjogren's Foundation
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2187: Association Between Illness Perception, Anxiety and Depression State, Disease Activity and Glucocorticoid Therapy in Patients with Sjӧgren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Chiara Baldini, MD, PhD – University of Pisa
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2188: Lung Cysts in Primary SS: New Findings on an Allegedly Innocuous Iiagnosis
    Location: Poster Hall
    Abstract Poster Presenter: Maria Zacarin, MD (she/her/hers) – State University of Campinas - UNICAMP
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2189: Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement
    Location: Poster Hall
    Abstract Poster Presenter: Chiara Baldini, MD, PhD – University of Pisa
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2190: Saliclick: A Novel Technology for Minimal Invasive Salivary Gland Biopsy in Suspected Sjögren’s Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Thomas Hügle, MD, PhD, MA – University Hospital Lausanne
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2191: Efficacy of anti-CD38 Treatment with Daratumumab in Two Cases of Refractory and Severe Sjogren Disease
    Location: Poster Hall
    Abstract Poster Presenter: Gaetane Nocturne, MD, PhD – APHP
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2192: New Inducible Mouse Model of Sjögren’s Syndrome Represents a Valuable Tool to Assess the Impact of Gene Knockout on the Disease’s Physiopathology
    Location: Poster Hall
    Abstract Poster Presenter: Dorian Parisis, MD – Hôpital Universitaire de Bruxelles - Hôpital Erasme
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2193: Anti-citrullinated Protein Antibodies in Sjögren’s Syndrome Define a Subset of Patients with Lower B Cell Activation Markers and Higher Risk of Lung Involvement
    Location: Poster Hall
    Abstract Poster Presenter: Chiara Baldini, MD, PhD – University of Pisa
    Sjögren’s syndrome
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2194: Association of Self-perceived Oral Health Status with ESSPRI Reported by Sjögren's Syndrome Patients
    Location: Poster Hall
    Abstract Poster Presenter: Oscar E. Alvarez-González, MD – Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León
    Sjögren’s syndrome
  • Wednesday, Nov 15th
    8:15 AM – 8:30 AM PT
    L18: Immune-metabolic Heterogeneity and Clinical Implications in Primary Sjogren's Syndrome Revealed by Molecular Classification of Salivary Glands
    Location: Room 6A-B
    Presenting Author: Huji Xu, n/a – Department of Rheumatology and Immunology, Changzheng Hospital, Naval Medical University
    Sjögren’s syndrome